Pharmaceutically acceptable salts of methyl (3-{ [[3-(6amino2-butoxy-8-oxo-7, 8-dihydro-9H-purin-9-yl) propyl] (3morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy

Details for Australian Patent Application No. 2008339095 (hide)

International Classifications

Event Publications

10 June 2010 PCT application entered the National Phase

PCT publication WO2009/078798 Priority application(s): WO2009/078798

3 May 2012 Application Accepted

Published as AU-B-2008339095

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.